Literature DB >> 2091930

Preliminary neuropsychological test results.

L M de Sonneville1, E Schmidt, U Michel, U Batzler.   

Abstract

A series of information processing tasks was administered to 22 PKU children aged 8.5 years who had been under dietary treatment since birth as well as to 20 controls of the same age. This contribution presents the results of two tasks from this series: a continuous performance task and a calculation task. The continuous performance task revealed a sustained attention deficit in the PKU group. In the calculation task the PKU children were slower than the controls and this difference increased with task difficulty. When the PKU sample was divided in two groups (above and below the median value of the concurrent plasma Phe level), the high Phe level group performed much worse in comparison to the low Phe level group. The latter group actually matched performance level of the controls. This could be observed for both tasks. The serum Phe level, assessed since birth over 6 month periods, correlated highly with task performance. As regards sustained attention, the Phe level measured during the 2 years preceeding test administration appeared to be an even better predictor for task performance than the concurrent Phe level, a finding which seems to underline the chronic effect of Phe on basic attention mechanisms. The results so far seem to stress the value of well-controlled dietary restrictions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2091930     DOI: 10.1007/BF02126298

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  10 in total

1.  Late sequelae of a non-optimal neonatal neurological condition in ERPs at the age of 11-13 years.

Authors:  L M De Sonneville; S L Visser; C Njiokiktjien
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1989-06

Review 2.  Sternberg's additive factor method and underlying psychological processes: some theoretical considerations.

Authors:  J P Pieters
Journal:  Psychol Bull       Date:  1983-05       Impact factor: 17.737

3.  Towards a model of stress and human performance.

Authors:  A F Sanders
Journal:  Acta Psychol (Amst)       Date:  1983-04

4.  Results of psychological testing of patients aged 3-6 years.

Authors:  U Michel; E Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

5.  Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations.

Authors:  U Wendel; K Ullrich; H Schmidt; U Batzler
Journal:  Eur J Pediatr       Date:  1990       Impact factor: 3.183

6.  Phenylketonuria and complex spatial visualization: an analysis of information processing.

Authors:  R L Brunner; D B Berch; H Berry
Journal:  Dev Med Child Neurol       Date:  1987-08       Impact factor: 5.449

7.  Neuropsychological studies on adolescents with phenylketonuria returned to phenylalanine-restricted diets.

Authors:  J T Clarke; R D Gates; S E Hogan; M Barrett; G W MacDonald
Journal:  Am J Ment Retard       Date:  1987-11

8.  Neuropsychological deficits in early treated phenylketonuric children.

Authors:  B F Pennington; W J van Doorninck; L L McCabe; E R McCabe
Journal:  Am J Ment Defic       Date:  1985-03

9.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

  10 in total
  9 in total

1.  Does a single plasma phenylalanine predict quality of control in phenylketonuria?

Authors:  A MacDonald; G W Rylance; D Asplin; S K Hall; I W Booth
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

2.  Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria.

Authors:  K Ullrich; J Weglage; C Oberwittler; M Pietsch; B Fünders; H van Eckhardstein; J P Colombo
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

3.  Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet.

Authors:  A MacDonald; G Rylance; S K Hall; D Asplin; I W Booth
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

4.  Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria.

Authors:  E Schmidt; P Burgard; A Rupp
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

5.  Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine).

Authors:  F Trefz; L de Sonneville; P Matthis; C Benninger; B Lanz-Englert; H Bickel
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

6.  Information processing in patients with early and continuously-treated phenylketonuria.

Authors:  B A Stemerdink; J J van der Meere; M W van der Molen; A F Kalverboer; M M Hendrikx; J Huisman; L W van der Schot; F M Slijper; F J van Spronsen; P H Verkerk
Journal:  Eur J Pediatr       Date:  1995-09       Impact factor: 3.183

7.  Psychological and social findings in adolescents with phenylketonuria.

Authors:  J Weglage; B Fünders; B Wilken; D Schubert; E Schmidt; P Burgard; K Ullrich
Journal:  Eur J Pediatr       Date:  1992-07       Impact factor: 3.183

8.  Phenylketonuria and some aspects of emotional development.

Authors:  M M Hendrikx; L W van der Schot; F M Slijper; J Huisman; A F Kalverboer
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

9.  Personality disorder in young women with treated phenylketonuria.

Authors:  S E Waisbren; J Zaff
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.